Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Posture disorders in patients with multiple sclerosis.]
Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b+CD4+ T Cells in the CNS during Progressive EAE.
Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.
Melatonin pathway genes are associated with progressive subtypes and disability status in multiple sclerosis among Finnish patients.
Eosinophilic Fasciitis Occurring under Treatment with Natalizumab for Multiple Sclerosis.
Alemtuzumab 3-year data show durable effect on MS disability
Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis.
A Large-Scale Study of Anxiety and Depression in People with Multiple Sclerosis: A Survey via the Web Portal of the UK MS Register.
Acute reversible periependymal ventricular enhancement in neuromyelitis optica.
Remote effects of intermittent theta burst stimulation of the human pharyngeal motor system.
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonb therapy in multiple sclerosis.
The autonomic balance predicts cardiac responses after the first dose of fingolimod.
miRNA in multiple sclerosis: search for novel biomarkers.
Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
Connective Tissue and its Growth Factor, CTGF, Distinguish the Morphometric and Molecular Remodeling of the Bladder in a Model of Neurogenic Bladder.
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
Lack of response to pulse cyclophosphamide in neuromyelitis optica: evaluation of 7 patients.
[Gluten-related disorders and demyelinating diseases.]
[Biosimilar of interferon-beta 1b in the treatment of multiple sclerosis and the own experience in the use of ronbetal.]
A cross-sectional study examining multiple mobility device use and fall status among middle-aged and older adults with multiple sclerosis.
Safety and efficacy extension study of daclizumab high yield process (DAC HYP) to treat relapsing remitting multiple sclerosis
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.
Intramuscular interferon beta-1a is effective in Japanese patients with relapsing-remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions.
Epstein-Barr virus, latitude and multiple sclerosis.
Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial.

Pages